Generics firms Amneal and Impax to merge
By 
Phillip Broadwith2017-11-07T15:48:00
Deal continues consolidation trend, based on portfolio expansion and simplifying supply chains
US-based generic drugmakers Amneal and Impax have agreed to merge, through an all-shares deal that the companies claim will push the combined firm into the top five US generics firms by revenue.